|
Subsequent Events (Details) (Subsequent event, Actavis plc (formerly Forest Laboratories Holdings Limited), USD $)
In Millions, unless otherwise specified |
1 Months Ended |
|---|---|
|
Mar. 31, 2015
person
|
|
|
Subsequent event | Actavis plc (formerly Forest Laboratories Holdings Limited)
|
|
| Subsequent events | |
| Payment received to fund expansion of clinical trial |
$ 10.0trvn_CollaborativeArrangementPaymentToFundExpansionOfClinicalTrial / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
| Number of patients before expansion of the trial |
500trvn_NumberOfPatientsBeforeExpansionOfTrial / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
| Number of patients after expansion of the trial |
620trvn_NumberOfPatientsAfterExpansionOfTrial / us-gaap_CounterpartyNameAxis = trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember / us-gaap_SubsequentEventTypeAxis = us-gaap_SubsequentEventMember |
| X | ||||||||||
|
- Definition
Represents the payment received to fund the expansion of a clinical trial. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the number of patients after the expansion of the trial. No definition available.
|
| X | ||||||||||
|
- Definition
Represents the number of patients before the expansion of the trial. No definition available.
|
| X | ||||||||||
|
- Details
|